Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Nutrients ; 9(4)2017 Apr 14.
Artigo em Inglês | MEDLINE | ID: mdl-28420095

RESUMO

Lipids have multiple physiological roles that are biologically vital. Soybean oil lipid emulsions have been the mainstay of parenteral nutrition lipid formulations for decades in North America. Utilizing intravenous lipid emulsions in parenteral nutrition has minimized the dependence on dextrose as a major source of nonprotein calories and prevents the clinical consequences of essential fatty acid deficiency. Emerging literature has indicated that there are benefits to utilizing alternative lipids such as olive/soy-based formulations, and combination lipids such as soy/MCT/olive/fish oil, compared with soybean based lipids, as they have less inflammatory properties, are immune modulating, have higher antioxidant content, decrease risk of cholestasis, and improve clinical outcomes in certain subgroups of patients. The objective of this article is to review the history of IVLE, their composition, the different generations of widely available IVLE, the variables to consider when selecting lipids, and the complications of IVLE and how to minimize them.


Assuntos
Emulsões Gordurosas Intravenosas/química , Emulsões Gordurosas Intravenosas/uso terapêutico , Lipídeos/uso terapêutico , Nutrição Parenteral , Óleos de Peixe/uso terapêutico , Humanos , Óleos de Plantas/uso terapêutico , Triglicerídeos/uso terapêutico
2.
Nutr Clin Pract ; 31(2): 229-34, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-26888855

RESUMO

RATIONALE: Parenteral nutrition (PN) may be provided through compounded or premixed solutions. OBJECTIVE: To determine the proportion of stable custom-compounded PN prescriptions that would fit within a 20% deviance of an existing premixed PN solution. METHODS: A retrospective study design was used. Inpatients who received PN in non-critical care units in the preceding year were screened for eligibility. Results are reported descriptively as means (95% confidence intervals) and proportions. RESULTS: We reviewed 97 PN prescriptions that met inclusion criteria. Stable hospital PN prescriptions compared with the reference premixed prescription provided 1838 (1777-1898) vs 1843 (1781-1905) kcal/d, P = .43; dextrose, 266 (254-277) vs 225 (216-234) g/d, P < .001; amino acids, 100 (95.9-104) vs 95.2 (91.7-98.7) g/d, P < .001; and lipids, 53.2 (51.3-55.1) vs 76.5 (73.8-79.2) g/d, P < .001. Fifty-eight of 97 (59.8%) matched for 2 of 3 macronutrients. Hospital compared with premixed lipid was lower 53.6 (43-64.2) g/d vs 75.5 (60.5-90.5) g/d, P < .001. Electrolytes differed between hospital and premixed solutions: sodium, 98.6 (95.0-102) vs 66.9 (64.6-69.9) mmol/L, P < .001; potassium, 93.7 (89.0-98.3) vs 57.4 (55.4-59.4) mmol/L, P < .001; and magnesium, 5.4 (4.8-5.4) vs 7.6 (7.4-7.9) mmol/L. CONCLUSIONS: Calories and protein were remarkably similar, but dextrose, lipid, and electrolytes differed between hospital PN and the reference premixed prescription. We believe that there may be a role for premixed solutions in quaternary centers in stable non-critically ill patients.


Assuntos
Soluções de Nutrição Parenteral/química , Nutrição Parenteral , Aminoácidos/análise , Gorduras na Dieta/análise , Proteínas Alimentares/análise , Eletrólitos/análise , Ingestão de Energia , Feminino , Glucose/análise , Hospitalização , Humanos , Unidades de Terapia Intensiva , Magnésio/análise , Masculino , Pessoa de Meia-Idade , Potássio/análise , Medicamentos sob Prescrição/química , Estudos Retrospectivos , Sódio/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA